SARS-CoV2 revisión bibliográfica
DOI:
https://doi.org/10.26820/reciamuc/4.(4).noviembre.2020.255-262Keywords:
Covid-19, Enfermedades, Cardiológico, Arritmias, SeveraAbstract
A finales del año 2019, una simple gripe como aparentemente se presumió, desató a nivel mundial lo que hoy es una pandemia, como la que se dio hace mucho tiempo, llamada “gripe española”. Este virus, inicio en la provincia de Hubei, en China; y posteriormente, se extendió de manera muy rápida al resto del mundo. En marzo de 2020, la Organización Mundial de la Salud (OMS), notificó a nivel mundial la pandemia del Coronavirus en pleno. Hoy en día, ya se puede combatir de forma más eficaz este síndrome respiratorio, teniendo un diagnóstico temprano, tratamiento oportuno y atenuando con esto las cifras de mortalidad y morbilidad por Covid-19. En este estudio, nuestro objetivo es proveer a la comunidad, servicio de salud pública y primer nivel de atención, de una revisión cautelosa y puntual de los aspectos esenciales relacionados al virus en mención, dando a conocer la epidemiología, el proceso fisiopatológico, diagnóstico, tratamiento y medidas de prevención. La investigación realizada tiene una metodología de revisión bibliográfica con bases en investigación científica de Pubmed, Medline y diversas revistas médicas indexadas, con el fin de que este artículo presente un aporte fiable a sus lectores.
Downloads
References
- Ahn DG, Shin HJ, Kim MH, Lee S, Kim HS, Myoung J, Kim BT, Kim SJ. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). J Microbiol Biotechnol. 2020 Mar 28;30(3):313-324. doi: 10.4014/jmb.2003.03011. PMID: 32238757.
- Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. 2020. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395: 565-574.
- Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. 2020. Severe acute respiratory syndrome-related coronavirus: the species and its viruses –a statement of the coronavirus study group. BioRxiv. 20200207: 937862.
- Fung TS, Liu DX. 2019. Human coronavirus: host-pathogen interaction. Annu. Rev. Microbiol. 73: 529-557.
- WHO Novel Coronavirus (2019-nCoV) SITUATION REPORT - 1 21 JANUARY 2020. Available from https:// www.who.int/docs/default-source/coronaviruse/situationreports/ 20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4.
- WHO Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Available from https://www.who.int/docs/default-source/coronaviruse/ 322 Ahn et al. J. Microbiol. Biotechnol. who-china-joint-mission-on-covid-19-final-report.pdf. Accessed 02 Mar. 2020.
- WHO Coronavirus disease 2019 (COVID-19) Situation Report – 55 (15 Mar 2020). Available from https://www.who.int/docs/default-source/coronaviruse/situationreports/20200315-sitrep-55-covid-19.pdf?sfvrsn=33daa5cb_8. Accessed 19 Mar. 2020.
- World Health Organization. Coronavirus disease (COVID-2019) situation reports. 2020. Available at: https:// www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/. Accessed December 1, 2020.
- Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19): cases in U.S. 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html. Accessed December 5, 2020.
- Jamshaid, H., Zahid, F., Din, I.u. et al. Diagnostic and Treatment Strategies for COVID-19. AAPS PharmSciTech 21, 222 (2020). https://doi.org/10.1208/s12249-020-01756-3
- De Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 14: 523–534, 2016. doi:10.1038/nrmicro.2016.81.
- Li F. Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits. J Virol 86: 2856–2858, 2012. doi:10. 1128/JVI.06882-11.
- Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367: 1260– 1263, 2020. doi:10.1126/science.abb2507.
- Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARSCoV-2 and other lineage B betacoronaviruses. Nat Microbiol 5: 562–569, 2020. doi:10.1038/ s41564-020-0688-y
- Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, Zhong W, Hao P. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 63: 457–460, 2020. doi:10.1007/s11427-020-1637-5.
- Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med 14: 185–192, 2020. doi:10. 1007/s11684-020-0754-0.
- Chan JFW, Kok KH, Zhu Z, Chu H, To KKW, Yuan S, Yuen KY. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 9: 221–236, 2020. doi: 10.1080/22221751.2020.1719902. A correction for this article is available at https://doi.org/10.1080/ 22221751.2020.1737364.
- Chen Y, Guo Y, Pan Y, Zhao ZJ. Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun 525: 135–140, 2020. doi: 10.1016/j.bbrc.2020.02.071.
- Matsuyama S, Ujike M, Morikawa S, Tashiro M, Taguchi F. Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc Natl Acad Sci USA 102: 12543– 12547, 2005. doi:10.1073/pnas.0503203102.
- Millet JK, Whittaker GR. Host cell entry of Middle East respiratory syndrome coronavirus after twostep, furin-mediated activation of the spike protein. Proc Natl Acad Sci USA 111: 15214–15219, 2014. doi:10.1073/pnas.1407087111.
- Mary Kathryn Bohn, Alexandra Hall, Lusia Sepiashvili, Benjamin Jung, Shannon Steele, and Khosrow Adeli Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression Physiology 2020 35:5, 288-301
- Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol 7: 439–450, 2009. doi:10.1038/ nrmicro2147
- Jin Y-H, Cai L, Cheng Z-S, Cheng H, Deng T, Fan Y-P, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7:4. https://doi.org/10.1186/s40779- 020-0233-6
- Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, et al. Detection of 2019 novel coronavirus (2019- nCoV) by real - time RT-PCR. Eurosur veillance. 2020;25:2000045. https://doi.org/10.2807/1560- 7917.ES.2020.25.3.2000045.
- Lim XF, Lee CB, Pascoe SM, How CB, Chan S, Tan JH, et al. Detection and characterization of a novel bat-borne coronavirus in Singapore using multiple molecular approaches. J Gen Virol. 2019;100:1363–74. https://doi.org/10.1099/jgv.0.001307.
- Carter LJ, Garner LV, Smoot JW, Li Y, Zhou Q, Saveson CJ, et al. Assay techniques and test development for COVID-19 diagnosis. ACS Publications; 2020.
- Wang X, Zhong M, Liu Y, Ma P, Dang L, Meng Q, et al. Rapid and sensitive detection of COVID-19 using CRISPR/Cas12abased detection with naked eye readout, CRISPR/Cas12a-NER. Sci Bull. 2020. https://doi.org/10.1016/j.scib.2020.04.041.
- Koczula KM, Gallotta A. Lateral flow assays. Essays Biochem. 2016;60:111–20. https://doi.org/10.1042/EBC20150012.
- BioMedomics. COVID-19 IgM/IgG Rapid Test. http:// www.biomedomics.com/products/infectious-disease/covid-19-rt/ (2020). Accessed 4 April 2020.
- Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S, et al. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol. 2020. https:// doi.org/10.1002/jmv.25727
